| #26 |
George Edward Andrew Bown |
Transense Technologies, Plc |
1 |
| #26 |
Richard Heap |
Faradion Limited |
1 |
| #26 |
Peter Randall |
Viavi Solutions Uk Limited |
1 |
| #26 |
Jonathan Silk |
Ludwig Institute For Cancer Research |
1 |
| #26 |
Zsolt John Laczik |
Isis Innovation Limited |
1 |
| #26 |
Andrew Michael Shand |
Schlumberger Technology |
1 |
| #26 |
Timothy Foster |
Good Humor-Breyers Ice Cream, Division Of Conopco |
1 |
| #26 |
Trevor Graham Tonkin |
Schlumberger Technology |
1 |
| #26 |
Chris Dettmar |
Intel |
1 |
| #26 |
Luca Letizia |
Schlumberger Technology |
1 |
| #26 |
Mark James Batchelor |
Vertex Pharmaceuticals Incorporated |
1 |
| #26 |
Renia Gemmell |
Mead Johnson Nutrition |
1 |
| #26 |
Mark James Le Feuvre |
Siemens Aktiengesellschaft |
1 |
| #26 |
Alan Hastings Drummond |
British Biotech Pharmaceuticals |
1 |
| #26 |
Colin Richard Dorgan |
Summit Corporation Plc |
1 |
| #26 |
Alasdair Stamps |
Oxford Biotherapeutics |
1 |
| #26 |
Michael Prime |
Chdi Foundation |
1 |
| #26 |
Alison Burdett |
Carefusion 303 |
1 |
| #26 |
Michael Price |
Cambridge Enterprise Limited |
1 |
| #26 |
Peter Eamon Molloy |
Immunocore Limited |
1 |
| #26 |
Christian Rohlff |
Oxford Biotherapeutics |
1 |